PGP and cancer: The results of lower intracellular ensartinib accumulation (Figure 3) and reduced ensartinib-induced apoptosis (Figure 4) in P-gp-overexpressing KB-V1 cancer cells compared to the parental KB-3-1 cells correspond directly to the cytotoxicity data.